Thus, our data reveal that cGAS is required for the type I IFN response in SAMHD1-KO monocytes, suggesting that inhibition of cGAS–STING signaling could prevent chronic type I IFN signaling in AGS and potentially ameliorate associated symptoms. Here, CGAS is linked to Aicardi-Goutieres syndrome.